BIOTECHNOLOGY & PUBLIC HEALTH
BIOTECHNOLOGY & PUBLIC HEALTH
Stacks Image 515
TODD BIXBY
CO-FOUNDER & CHIEF EXECUTIVE OFFICER
PLANETARY GENETICS
www.planetary-genetics.com

CO-FOUNDER & PRINCIPAL
ROSSI BIXBY + ASSOCIATES
www.rossibixby.com
Biotechnology and public health professional with over 20 years experience developing, deploying and evaluating technologies applicable to human and animal health, food, and environmental interventions, as well as, national security, conservation, sustainable agriculture, waste-to-value, biofuels, and consumer products.

Multi-disciplinary expertise gained functioning in technology analysis, basic and applied research, new product development, project management, marketing, business development, strategic alliances, and leadership roles.
Stacks Image 462
TODD BIXBY
CO-FOUNDER & CHIEF EXECUTIVE OFFICER | PLANETARY GENETICS | www.planetary-genetics.com
CO-FOUNDER & PRINCIPAL | ROSSI BIXBY + ASSOCIATES |
www.rossibixby.com
Biotechnology and public health professional with over 20 years experience developing, deploying and evaluating technologies applicable to human and animal health, food, and environmental interventions, as well as, national security, conservation, sustainable agriculture, waste-to-value, biofuels, and consumer products.

Multi-disciplinary expertise gained functioning in technology analysis, basic and applied research, new product development, project management, marketing, business development, strategic alliances, and leadership roles.
Stacks Image 524
TODD BIXBY
CO-FOUNDER & CHIEF EXECUTIVE OFFICER | PLANETARY GENETICS
www.planetary-genetics.com

CO-FOUNDER & PRINCIPAL | ROSSI BIXBY + ASSOCIATES
www.rossibixby.com
Biotechnology and public health professional with over 20 years experience developing, deploying and evaluating technologies applicable to human and animal health, food, and environmental interventions, as well as, national security, conservation, sustainable agriculture, waste-to-value, biofuels, and consumer products.

Multi-disciplinary expertise gained functioning in technology analysis, basic and applied research, new product development, project management, marketing, business development, strategic alliances, and leadership roles.
HIGHLIGHTS
HIGHLIGHTS
HEALTH TECHNOLOGY
  • Current R&D effort: quantitative serological SARS-CoV-2 (COVID) assay for protective neutralizing antibodies (redirect to www.planetary-genetics.com)
  • Developed groundbreaking FDA cleared products including current molecular tests ensuring safety of U.S. blood supply (HIV, HCV, HBV, West Nile Virus)
  • Launched first combined Chlamydia and Gonorrhea molecular tests, eliminating need for male genital swabbing using male/female urine specimens
  • Developed and advanced numerous diagnostic, therapeutic, and vaccine health technologies with molecular, genetic, and genome engineering platforms

GLOBAL PUBLIC HEALTH & NATIONAL SECURITY
  • Engineering SARS-CoV-2 Sewer Surveillance Systems and environmental testing platforms to help contain the spread of COVID-19 and future threats
  • Pioneered HIV CD4 mobile testing interventions in Sub-Saharan Africa to ensure efficacy of HIV anti-retroviral therapies (ART) in rural low resource settings
  • Epidemic responses: COVID-19 pandemic, Zika, dengue, malaria, tuberculosis, HIV, influenza, Chlamydia, and Gonorrhea
  • Expertise in molecular epidemiology, epidemic intelligence, environmental health, infectious disease control, and biological threat detection systems
  • Advanced numerous biodefense and biosecurity medical countermeasure technologies: diagnostics and detection systems, vaccines, therapeutics

FOOD TECHNOLOGY

  • Advancing genetic and genome engineering technologies for animal-free foods (redirect to www.planetary-genetics.com)
  • Advanced food biotechnology for first-in-class synthetic biology enabled food products and agricultural innovations
  • Deep expertise with gene-edited, genetically engineered, and cloned organisms serving as first-in-class for US FDA and USDA regulators

ENVIRONMENTAL INTERVENTIONS & CONSERVATION
  • Developed multiple environmental threat detection systems for biosecurity
  • Pioneered development of gene-edited environmental clean-up systems for emerging contaminants of concern (COCs) [e.g., 1,4-dioxane]
  • Deep expertise with gene-edited, genetically engineered, and cloned organisms serving as first-in-class for US EPA and US FWS regulators
  • Advancing technologies for water safety testing, environmental health, ocean conservation, and marine natural products chemistries discovery
HEALTH TECHNOLOGY
  • Current R&D effort: quantitative serological SARS-CoV-2 (COVID) assay for protective neutralizing antibodies (redirect to www.planetary-genetics.com)
  • Developed groundbreaking FDA cleared products including current molecular tests ensuring safety of U.S. blood supply (HIV, HCV, HBV, West Nile Virus)
  • Launched first combined Chlamydia and Gonorrhea molecular tests, eliminating need for male genital swabbing using male/female urine specimens
  • Developed and advanced numerous diagnostic, therapeutic, and vaccine health technologies with molecular, genetic, and genome engineering platforms

GLOBAL PUBLIC HEALTH & NATIONAL SECURITY

  • Engineering SARS-CoV-2 Sewer Surveillance Systems and environmental testing platforms to help contain the spread of COVID-19 and future threats
  • Pioneered HIV CD4 mobile testing interventions in Sub-Saharan Africa to ensure efficacy of HIV anti-retroviral therapies (ART) in rural low resource settings
  • Epidemic responses: COVID-19 pandemic, Zika, dengue, malaria, tuberculosis, HIV, influenza, Chlamydia, and Gonorrhea
  • Expertise in molecular epidemiology, epidemic intelligence, environmental health, infectious disease control, and biological threat detection systems
  • Advanced numerous biodefense and biosecurity medical countermeasure technologies: diagnostics and detection systems, vaccines, therapeutics

FOOD TECHNOLOGY

  • Advancing genetic and genome engineering technologies for animal-free foods (redirect to www.planetary-genetics.com)
  • Advanced food biotechnology for first-in-class synthetic biology enabled food products and agricultural innovations
  • Deep expertise with gene-edited, genetically engineered, and cloned organisms serving as first-in-class for US FDA and USDA regulators

ENVIRONMENTAL INTERVENTIONS & CONSERVATION
  • Developed multiple environmental threat detection systems for biosecurity
  • Pioneered development of gene-edited environmental clean-up systems for emerging contaminants of concern (COCs) [e.g., 1,4-dioxane]
  • Deep expertise with gene-edited, genetically engineered, and cloned organisms serving as first-in-class for US EPA and US FWS regulators
  • Advancing technologies for water safety testing, environmental health, ocean conservation, and marine natural products chemistries discovery
HEALTH TECHNOLOGY
  • Current R&D effort: quantitative serological SARS-CoV-2 (COVID) assay for protective neutralizing antibodies (redirect to www.planetary-genetics.com)
  • Developed groundbreaking FDA cleared products including current molecular tests ensuring safety of U.S. blood supply (HIV, HCV, HBV, West Nile Virus)
  • Launched first combined Chlamydia and Gonorrhea molecular tests, eliminating need for male genital swabbing using male/female urine specimens
  • Developed and advanced numerous diagnostic, therapeutic, and vaccine health technologies with molecular, genetic, and genome engineering platforms

GLOBAL PUBLIC HEALTH & NATIONAL SECURITY

  • Engineering SARS-CoV-2 Sewer Surveillance Systems and environmental testing platforms to help contain the spread of COVID-19 and future threats
  • Pioneered HIV CD4 mobile testing interventions in Sub-Saharan Africa to ensure efficacy of HIV anti-retroviral therapies (ART) in rural low resource settings
  • Epidemic responses: COVID-19 pandemic, Zika, dengue, malaria, tuberculosis, HIV, influenza, Chlamydia, and Gonorrhea
  • Expertise in molecular epidemiology, epidemic intelligence, environmental health, infectious disease control, and biological threat detection systems
  • Advanced numerous biodefense and biosecurity medical countermeasure technologies: diagnostics and detection systems, vaccines, therapeutics

FOOD TECHNOLOGY

  • Advancing genetic and genome engineering technologies for animal-free foods (redirect to www.planetary-genetics.com)
  • Advanced food biotechnology for first-in-class synthetic biology enabled food products and agricultural innovations
  • Deep expertise with gene-edited, genetically engineered, and cloned organisms serving as first-in-class for US FDA and USDA regulators

ENVIRONMENTAL INTERVENTIONS & CONSERVATION
  • Developed multiple environmental threat detection systems for biosecurity
  • Pioneered development of gene-edited environmental clean-up systems for emerging contaminants of concern (COCs) [e.g., 1,4-dioxane]
  • Deep expertise with gene-edited, genetically engineered, and cloned organisms serving as first-in-class for US EPA and US FWS regulators
  • Advancing technologies for water safety testing, environmental health, ocean conservation, and marine natural products chemistries discovery
BIOSKETCH
Mr. Bixby has been advancing biotechnology to benefit the public health across applications spanning food tech, diagnostics, therapeutics, biodefense, bioremediation, and invasive species control interventions, globally for over 20 years.

His experience as a life sciences, biotechnology and public health professional has focused on development of advanced technologies with applications applicable to human and animal health, food, and environmental interventions, as well as, national security, conservation, sustainable agriculture, waste-to-value, biofuels, and consumer products.

He has cross-functional experience developing, deploying and evaluating technologies for clinical, public health, and biodefense programs including biological threat detection systems and various therapeutic and vaccine medical countermeasures. Additionally, his technical and commercial experience with international launching of advanced technologies has been informed by having helped develop multiple infectious disease diagnostics including molecular tests for the safety of the U.S. blood supply and other nations, which also greatly enhanced later efforts to evaluate and deploy critical diagnostic interventions in low resource settings across developing countries in Sub-Saharan Africa.

His world view has been further formed through graduate research in epidemiology with strong focus in governmental and regulatory policies affecting environmental and public health, biotechnology, synthetic biology and genetic engineering. Mr. Bixby has gained multi-disciplinary expertise functioning in technology analysis, basic and applied research, new product development, project management, marketing, business development, strategic alliances, and leadership roles.

Mr. Bixby is also a great proponent of interventions aimed at Public Health and One Health, Planetary Health.
LINKS
CONTACT
info@toddbixby.com

ADVANCING BIOTECHNOLOGY FOR PUBLIC HEALTH, ONE HEALTH, PLANETARY HEALTH

ADVANCING BIOTECHNOLOGY FOR PUBLIC HEALTH, ONE HEALTH, PLANETARY HEALTH

Stacks Image 152
We can’t solve problems by using the same kind of thinking we used when we created them.
A.E.
We can’t solve problems by using the same kind of thinking we used when we created them.
A.E.

ONE HEALTH, PLANETARY HEALTH.

ONE HEALTH focuses on the interconnectedness of the health and well-being of humans, animals and ecosystems. Our health depends on healthy connections between those ecosystems.

PLANETARY HEALTH reframes the ENVIRONMENTAL and GLOBAL HEALTH challenges in terms that help make them self-evident.

ENVIRONMENTAL HEALTH and PUBLIC HEALTH are ultimately measures of the PLANET'S GENETICS, which is to say ALL THE GENES, interacting with each other and their environments under the pressure of time.

Learn more here about how PLANETARY GENETICS LLC is advancing new technology ventures for a healthier planet.

Stacks Image 492

HUMANS

Stacks Image 495

ANIMALS

Stacks Image 498

ECOSYSTEMS

NEWS

2 OCT 2020: ROSSI BIXBY + ASSOCIATES – We are pleased to announce availability to support new projects moving into Fall of 2020 and early 2021. We are grateful for the wonderful response to our formation this past Spring and are excited for the increased bandwidth to support initiatives we think make a difference. Feel free to visit www.rossibixby.com and our LinkedIn page to connect. Looking forward!

14 MAY 2020: ROSSI BIXBY + ASSOCIATES | IMPACT & STRATEGIC CONSULTING
announced our official formation in Spring 2020. Visit www.rossibixby.com to learn more. We're excited.

COVID-19 RESPONSE UPDATE (MAR 2020)
: At this critical time, I am happy to report the Planetary Genetics team is working to respond to the COVID pandemic by advancing diagnostics for quantitative neutralizing antibodies to SARS-CoV-2. Read more here.

CONFERENCES: Attended the INTERNATIONAL PLANT & ANIMAL GENOME CONFERENCE in San Diego, CA, January 11-15, 2020. Looking forward to re-connecting. Request a follow-up meeting here.

PLANETARY GENETICS LLC announced its formation in May 2019. Learn more about our mission at www.planetary-genetics.com.
We can’t solve problems by using the same kind of thinking we used when we created them.
A.E.

EVENTS

Given scheduling changes associated with COVID-19, this events schedule is in flux. Look forward to electronic connections on a path to returning to social interactions. Feel free to follow-up regarding meeting related events via email to info@toddbixby.com.
International Plant & Animal Genome Conference
The International Conference on the Status of Plant & Animal Genome Research

San Diego, CA
January 11-15, 2020
Beta Space
The unconvention for the space settlement community™

Mojave Desert, CA
To be rescheduled
American Public Health Association Annual Meeting
Creating the Healthiest Nation

San Francisco, CA
October 24-28, 2020

***

Association for Molecular Pathology Annual Meeting

Vancouver, British Columbia, Canada
November 17-21, 2020